{"infobox":{"dc_creator":"WooScraper_v1","dc_date_year":2012,"dc_identifier":"nl.oorg10123.2j.2012.576","dc_publisher":"oorg10123","dc_publisher_name":"Rijksinstituut voor Volksgezondheid en Milieu","dc_source":"https://www.rivm.nl/publicaties/guillain-barre-syndrome-and-adjuvanted-pandemic-influenza-a-h1n1-2009-vaccine","dc_title":"Guillain-Barre syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: multinational case-control study in Europe | RIVM","dc_type":"2j","dc_type_description":"2j - Onderzoek","foi_extraMetadata":{},"foi_files":[],"foi_isWoo":"Ja","foi_page_title":"Onderzoek Rijksinstituut voor Volksgezondheid en Milieu","foi_publishedDate":"2012-02-27","foi_retrievedDate":"2024-11-30","tooiwl_type":"c_fdaee95e"},"resource":"nl.oorg10123.2j.2012.576"}